Given the short timeframe of the GLP-1 demonstration, it is unlikely that there will be cost offsets from improved health due to increased GLP-1 use for obesity that can be documented
Through ongoing collaborative research and clinical trials, the efficacy and safety of GLP-1 agonists as adjunctive therapy continue to be clarified, providing fresh hope for individuals grappling with bipolar disorder
The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent
By reducing these external stressors, you allow your glutathione levels to work on internal repair rather than constant firefighting
Lets Keep You Healthy, Together The Medicare Wellness Visit is your chance to pause, plan, and protect your future health
Diabetes 56:19511959 Eissele R, Gke R, Willemer S et al (1992) Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man